TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07690189: Study of NTB-928 in R/R OC

Sponsor: TeneoSeven, Inc. · Phase: PHASE1 · Area: ONCOLOGY · Target Enrollment: 90 pts

Competing Trials Overlap

5 Active Trials

Excess Burn Exposure

$10,053,120

Rescue Site Savings

+$6,628,776

Unlock Full NCT07690189 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07690189 Rescue Dossier →